Ixabepilone/epiribicin combination as therapy for metastatic breast cancer - a phase Ib study

被引：0
|
作者：
Roche, H. [1 ]
Zambetti, M. [2 ]
Dalenc, F. [1 ]
De Benedictis, E. [2 ]
Gladieff, L. [1 ]
Mudenda, B. [3 ]
Messina, M. [3 ]
Lainas, I. [4 ]
Gianni, L. [2 ]
机构：
[1] Inst Claudius Regaud, Dept Med Oncol, I-20133 Toulouse, France
[2] Ist Nazl Studio & Cura Tumori, Dept Med Oncol, Milan, Italy
[3] Bristol Myers Squibb Co, Dept Med Oncol, Wallingford, CT USA
[4] Braine Alleud, Dept Med Oncol, Brussels, Belgium
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70915-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 268
页数：2
相关论文
共 50 条
  • [21] A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer
    Zhang, Qingyuan
    Shao, Bin
    Tong, Zhongsheng
    Ouyang, Quchang
    Wang, Yuting
    Xu, Guoying
    Li, Shaorong
    Li, Huiping
    BMC MEDICINE, 2022, 20 (01)
  • [22] Phase Ib study of rebastinib plus antitubulin therapy with paclitaxel or eribulin in patients with metastatic breast cancer (MBC).
    Mesias, Jesus Del Santo Anampa
    Oktay, Maja H.
    Xue, Xiaonan
    Condeelis, John
    Sparano, Joseph A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Combination of docetaxel and mitoxantrone for the therapy of metastatic breast cancer - a phase I-II study
    von Minckwitz, G
    Costa, SD
    Loibl, S
    Caminada, MC
    Kaufmann, M
    TUMORDIAGNOSTIK & THERAPIE, 1998, 19 (05) : 149 - 154
  • [24] Phase II Trial of Ixabepilone Plus Carboplatin in Patients with Metastatic Breast Cancer: The ECLIPSE Study.
    Osborne, C.
    Challagalla, J. D.
    Fanning, S. R.
    Eisenbeis, C. F.
    Holmes, F. A.
    Monaghan, G. G.
    Neubauer, M. A.
    Rabe, A. C.
    Raja, V.
    Robbins, G. J.
    Taboada, C.
    Vukelja, S. J.
    Wilks, S. T.
    Wang, Y.
    Brown, J-A
    Asmar, L.
    O'Shaughnessy, J.
    CANCER RESEARCH, 2011, 71
  • [25] A phase II study of ixabepilone plus trastuzumab for metastatic HER2-positive breast cancer
    Tolaney, S. M.
    Najita, J.
    Chen, W.
    Savoie, J.
    Fornier, M.
    Krop, I. E.
    Winer, E. P.
    Bunnell, C.
    CANCER RESEARCH, 2009, 69 (02) : 243S - 243S
  • [26] Carboplatin in combination therapy for metastatic breast cancer
    Perez, EA
    ONCOLOGIST, 2004, 9 (05): : 518 - 527
  • [27] COMBINATION THERAPY IN METASTATIC BREAST-CANCER
    CZIRAKI, L
    OO, M
    ANNALS OF INTERNAL MEDICINE, 1977, 86 (03) : 364 - 365
  • [28] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC)
    Thach-Giao Truong
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC).
    Truong, Thach-Giao
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [30] Ixabepilone, a New Treatment Option for Metastatic Breast Cancer
    Toppmeyer, Deborah L.
    Goodin, Susan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 516 - 521
12345